Insmed Incorporated
INSM
$68.12
$0.901.34%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -11.12% | 11.79% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -11.12% | 11.79% | |||
| Cost of Revenue | -18.63% | 23.53% | |||
| Gross Profit | -8.62% | 8.35% | |||
| SG&A Expenses | 3.53% | 19.83% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.72% | 19.67% | |||
| Operating Income | 6.27% | -23.38% | |||
| Income Before Tax | -9.13% | -6.73% | |||
| Income Tax Expenses | -27.96% | 24.85% | |||
| Earnings from Continuing Operations | -8.93% | -6.81% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -8.93% | -6.81% | |||
| EBIT | 6.27% | -23.38% | |||
| EBITDA | 6.49% | -23.63% | |||
| EPS Basic | -7.82% | -3.66% | |||
| Normalized Basic EPS | 5.67% | -18.01% | |||
| EPS Diluted | -7.92% | -3.61% | |||
| Normalized Diluted EPS | 5.67% | -18.01% | |||
| Average Basic Shares Outstanding | 1.03% | 3.05% | |||
| Average Diluted Shares Outstanding | 1.03% | 3.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||